Fatty acid synthesis

Last updated: November 01, 2022

Fatty acid synthesis

Block 2

Block 2

Pentose phosphate pathway
Diabetes mellitus
Disorders of carbohydrate metabolism: Pathology review
Amino acid metabolism
Disorders of amino acid metabolism: Pathology review
Dyslipidemias: Pathology review
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Diabetes mellitus (Type 2): Clinical sciences
Fatty acid synthesis
Wernicke-Korsakoff syndrome
Alcohol-induced hepatitis: Clinical sciences
Diabetes mellitus: Clinical
Diabetes mellitus (Type 1): Clinical sciences
Fetal alcohol syndrome
Diabetes mellitus: Pathology review
Alcohol use disorder
Alcohol-associated liver disease
Enterococcus
Staphylococcus epidermidis
Mycobacterium tuberculosis (Tuberculosis)
Neisseria gonorrhoeae
Corynebacterium diphtheriae (Diphtheria)
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Vitamin D
Klebsiella pneumoniae
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Streptococcus viridans
Clostridium perfringens
Chlamydia trachomatis
Staphylococcus saprophyticus
Staphylococcus aureus
Mycobacterium leprae
Clostridium botulinum (Botulism)
Bacillus anthracis (Anthrax)
Actinomyces israelii
Clostridium tetani (Tetanus)
Streptococcus agalactiae (Group B Strep)
Bacillus cereus (Food poisoning)
Listeria monocytogenes
Pseudomonas aeruginosa
Nocardia
Haemophilus influenzae
Neisseria meningitidis
Treponema pallidum (Syphilis)
Human papillomavirus
Herpes simplex virus
Neuraminidase inhibitors
Human herpesvirus 6 (Roseola)
Borrelia burgdorferi (Lyme disease)
Adenovirus
Yersinia pestis (Plague)
Rhinovirus
Rubella virus
Influenza virus
Mumps virus
Measles virus
Human herpesvirus 8 (Kaposi sarcoma)
Herpesvirus medications
Plasmodium species (Malaria)
Coxiella burnetii (Q fever)
Ehrlichia and Anaplasma
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Anthelmintic medications
Antimalarials
Trypanosoma cruzi (Chagas disease)
Francisella tularensis (Tularemia)
Candida
Anti-mite and louse medications
Miscellaneous antifungal medications
Azoles
Cytokines
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Hyper IgM syndrome
Leukocyte adhesion deficiency
Chronic granulomatous disease
X-linked agammaglobulinemia
Wound healing
Complement deficiency
Inflammation
Pulmonary corticosteroids and mast cell inhibitors
Selective immunoglobulin A deficiency
Necrosis and apoptosis
Ischemia
Wiskott-Aldrich syndrome
Immunodeficiencies: Clinical
Non-corticosteroid immunosuppressants and immunotherapies
Intrinsic hemolytic normocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Blood groups and transfusions
Macrocytic anemia: Pathology review
Cytomegalovirus infection after transplant (NORD)
Glucocorticoids
Blood products and transfusion: Clinical
Acute intermittent porphyria
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Aplastic anemia
Sideroblastic anemia
Microcytic anemia: Pathology review
Erythropoietin
Post-transplant lymphoproliferative disorders (NORD)
Platelet disorders: Pathology review
Thrombotic thrombocytopenic purpura
Neonatal jaundice: Clinical
Jaundice: Clinical
Mixed platelet and coagulation disorders: Pathology review
Von Willebrand disease
Immune thrombocytopenia
Hemolytic-uremic syndrome
Extrinsic hemolytic normocytic anemia: Pathology review
Jaundice
Iron deficiency anemia
Anemia: Clinical
Graft-versus-host disease
Iron deficiency anemia: Clinical sciences
Autoimmune hemolytic anemia
Severe chronic neutropenia (NORD)
Anemia of chronic disease: Year of the Zebra
Jaundice: Pathology review
Blood transfusion reactions and transplant rejection: Pathology review
Anemia of chronic disease
Non-hemolytic normocytic anemia: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Protein synthesis inhibitors: Aminoglycosides
Nucleotide metabolism
Adenosine deaminase deficiency
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Gout
Gout and pseudogout: Pathology review
Lesch-Nyhan syndrome
Gout: Clinical sciences
Oncogenes and tumor suppressor genes
Anti-tumor antibiotics
Blood histology
DNA synthesis inhibitors: Metronidazole
Deep vein thrombosis
Disseminated intravascular coagulation
Factor V Leiden
Protein C deficiency
Protein S deficiency
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Antithrombin III deficiency
Heparin-induced thrombocytopenia
Antiphospholipid syndrome
Hemophilia
Hemophilia: Year of the Zebra
Protease inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Hepatitis medications
HIV and AIDS: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Mechanisms of antibiotic resistance
Coagulation disorders: Pathology review
Integrase and entry inhibitors
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Lymphomas: Pathology review
Chronic leukemia
Acute leukemia
Non-Hodgkin lymphoma
Polycythemia vera (NORD)
Myelodysplastic syndromes
Hodgkin lymphoma
Essential thrombocythemia (NORD)
Waldenstrom macroglobulinemia
Multiple myeloma: Clinical sciences
Mastocytosis (NORD)
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Spleen histology
Myelofibrosis (NORD)
Lymphoma: Clinical
Varicella zoster virus
Coxsackievirus
Congenital TORCH infections: Pathology review
Streptococcus pyogenes (Group A Strep)
Lyme disease: Clinical sciences
Cortisol
Hematopoietic medications
Parvovirus B19
HIV (AIDS)
Zika virus

Transcript

Watch video only

In addition to carbohydrates and proteins, lipids are the third main macromolecule we consume in our diet.

Fatty foods include red meat, dairy products, and even peanut butter.

And lipids come in many forms, including cholesterol, glycerol, phospholipids, and fatty acids.

Of these, fatty acids are the simplest form of lipids - they’re basically just long chains of carbon and hydrogen, that are grouped by length into short, medium, long and very long chain fatty acids.

Fatty acids can also combine with glycerol to make triacylglycerides, which is made of 3 fatty acids attached to a glycerol molecule, and is the main storage form of fat in our body.

Now, short and medium-chain fatty acids are primarily obtained from the diet, but the liver and fat cells can synthesize long chain fatty acids.

This occurs by combining lots of 2-carbon molecules, called acetyl-coenzyme A or acetyl-CoA, into a single 16-carbon, long chain fatty acid called palmitoyl-coenzyme A, or palmitoyl-CoA.

Palmitoyl-CoA can then serve as a precursor to even longer chain fatty acids.

To make palmitoyl-CoA, acetyl-CoA provides the carbon atoms, and nicotinamide adenine dinucleotide phosphate, or NADPH provides the hydrogen atoms.

As it turns out, most of the acetyl-CoA used to make fatty acids comes from carbohydrate metabolism - specifically glucose, which is a 6-carbon sugar molecule.

After eating a glucose-rich dinner, like cake and cookies, glucose levels in the blood rise quickly.

In response, the pancreas secretes insulin, a hormone which makes our cells take in and process a lot more glucose.

Inside the cells, glucose can enter glycolysis where it’s broken down into two 3-carbon pyruvate molecules, and that yields a bit of energy in the form of adenosine triphosphate - or ATP.

Pyruvate then moves into the mitochondria, and is converted to acetyl-CoA by an enzyme called pyruvate dehydrogenase.

Inside the mitochondria, acetyl CoA enters the citric acid cycle by combining with a molecule called oxaloacetate, to form citrate.

Citrate can then continue in the citric acid cycle, which generates electron carriers that can join the electron transport chain and oxidative phosphorylation.

All of this leads to the formation of a lot more ATP.

So the math is simple - more glucose, more ATP.

Well, ATP inhibits some enzymes in the citric acid cycle, slowing it down overall, and that means that extra acetyl-CoA can be used to make fatty acids instead.

However, the enzymes required for fatty acid synthesis are all in the cytoplasm, so in order to start fatty acid synthesis, acetyl-CoA needs to get out of the mitochondria.

Unfortunately, acetyl-CoA cannot cross the mitochondrial membrane - so to get to the cytoplasm, it combines with oxaloacetate to form citrate, just as it would to enter the citric acid cycle.

So when there’s a lot of ATP around, citrate crosses the mitochondrial membrane and enters the cytoplasm.

In the cytoplasm, an enzyme called citrate lyase, cleaves citrate back into acetyl-CoA and oxaloacetate.

This process of conversion and reconversion is called the citrate shuttle.

In the meantime, oxaloacetate is recycled and goes back into the mitochondria so it can be available the next incoming acetyl-CoA.

But we have another problem; oxaloacetate can’t cross the membrane either.

So an enzyme called malic enzyme, converts oxaloacetate into pyruvate, forming NADPH from NADP+ in the process.

Now, pyruvate can cross the mitochondrial membrane, and an enzyme called pyruvate carboxylase converts it back into oxaloacetate, which can begin a new cycle.

High levels of acetyl-CoA also increase the activity of pyruvate carboxylase, so that oxaloacetate is made available.

With acetyl-CoA in the cytoplasm, all we need to begin fatty acid synthesis is NADPH to provide the hydrogens.

Some of that NADPH is generated by malic enzyme when it converts oxaloacetate to pyruvate.

And the rest comes from the metabolism of the excess glucose in a pathway called the pentose-phosphate pathway.

Once there’s enough NADPH, acetyl-CoA can begin its journey towards palmitoyl-CoA.

Ok, so first, a carboxyl group is added to acetyl-CoA by an enzyme called acetyl-CoA carboxylase, converting it to the 3-carbon malonyl-CoA.

This enzyme requires 3 cofactors, which can be easily remembered with the mnemonic, ABC.

“A” is for ATP, “B” is for biotin, or vitamin B7, and “C” is for carbon dioxide, or CO2, which is the carboxyl group source.

Key Takeaways

Fatty acids are one of the essential forms of energy storage. The biosynthesis of fatty acids is a multi-step process in the cytoplasm, mainly of the liver and fat cells. The process takes place in three major steps: the citrate shuttle, acetyl-CoA carboxylase (the rate-limiting step), and fatty acid synthase complex.